# How to Check a Company's FDA Approval and Clearance Status: A Healthcare Investor's Step-by-Step Guide

> Verifying FDA approval and clearance status is one of the most critical steps in healthcare due diligence. This guide walks investors through every primary source, common pitfalls, and a practical checklist to confirm exactly what a medical device or drug company actually has cleared, approved, or pending.

## Why FDA Status Verification Matters Before You Invest

FDA approval or clearance status is the single most important regulatory milestone a healthcare company can claim, and it is also one of the most frequently misrepresented facts in investor materials. A company may say it has FDA clearance when it has only received a breakthrough device designation. It may describe a 510(k) clearance as equivalent to full PMA approval. Before committing capital, you need to verify directly from FDA primary sources, not from a press release or investor deck.

The good news: the FDA publishes comprehensive, searchable databases that are free and publicly accessible. The work is in knowing which database to use, what the output actually means, and how to cross-reference it against what the company is claiming.

## Which FDA Database Should You Search for Drugs vs. Devices?

The answer depends on the product type, and using the wrong database is one of the most common investor mistakes.

**For prescription drugs and biologics:** Use the FDA Drugs@FDA database at fda.gov. Search by company name, active ingredient, or NDA/BLA number. Each approved drug entry shows the application type (NDA, ANDA, BLA), approval date, approved indication, labeling history, and any Risk Evaluation and Mitigation Strategy (REMS) requirements. Drugs approved under accelerated approval will be flagged, which matters because they carry ongoing post-market study requirements.

**For medical devices (510k clearances):** Use the FDA 510(k) database at fda.gov/medical-devices/databases. Search by applicant name, device name, or 510(k) number. The result tells you the decision date, the predicate device used to establish substantial equivalence, the device classification, and any special conditions. Critically, 510(k) clearance does NOT mean the device is proven safe and effective through clinical trial evidence. It means the FDA determined it is substantially equivalent to a legally marketed predicate. Many investors conflate clearance with approval, which are two legally distinct standards.

**For high-risk devices (PMA approvals):** Use the PMA database at fda.gov/medical-devices/databases. PMA approval requires the highest level of evidence, including valid scientific evidence demonstrating reasonable assurance of safety and effectiveness. Check the approval order, the summary of safety and effectiveness data (SSED), and any post-approval study requirements.

**For De Novo classifications:** Use the De Novo database. De Novo is a pathway for novel low-to-moderate risk devices with no predicate. It creates a new device classification and is meaningfully different from both 510(k) and PMA.

## How Do You Verify What a Company Claims in Its Press Releases?

Always triangulate three sources: the FDA database entry, the company SEC filing, and the company press release. Discrepancies between these three are immediate red flags.

On SEC EDGAR (sec.gov/cgi-bin/browse-edgar), pull the company's most recent 10-K and any 8-K filings from around the date of the claimed approval. The 10-K risk factors section will reveal any conditions, limitations, or post-market commitments attached to the approval. An 8-K filed at the time of clearance will include the actual FDA letter number you can verify against the FDA database.

Check the exact approved indication language in the FDA database against what the company says in its marketing. Companies sometimes promote products for uses beyond the cleared or approved indication, a practice called off-label promotion, which creates regulatory and legal exposure investors should price into their risk model.

## What Do Pending Applications and Breakthrough Designations Actually Mean?

Designations such as Breakthrough Device, Fast Track, Breakthrough Therapy, and Priority Review are process advantages granted by FDA to speed review. They are not approvals. They do not guarantee approval. This distinction is critical because companies routinely use designation announcements to generate investor interest.

To verify designation status: for drugs, search the FDA database for Breakthrough Therapy designation records or check the company 10-K disclosure. For devices, the FDA publishes a Breakthrough Device Program database. For pending applications, the FDA does not publish a real-time application status database for most submissions, so you must rely on company disclosures in SEC filings and confirm PDUFA action dates (for drugs) which are often disclosed in 10-K or 10-Q filings.

For clinical trials tied to pending applications, cross-reference ClinicalTrials.gov using the NCT number. Check enrollment status, primary endpoint definitions, and whether results have been posted. A company claiming an NDA submission should have a completed Phase 3 trial with posted results.

## What Are the Most Common Red Flags in FDA Status Claims?

These patterns appear repeatedly in healthcare investment fraud and overhyped early-stage companies:

- Claiming 510(k) clearance as equivalent to FDA approval of clinical efficacy
- Describing a Breakthrough Device designation as regulatory approval
- Citing an approval in a foreign jurisdiction (CE mark, Health Canada) as equivalent to FDA clearance
- Referencing an FDA approval that was later withdrawn or had its indication narrowed via a label change
- Omitting post-market study requirements that could result in withdrawal if not met
- Using the phrase cleared by the FDA for a product that has only received an Investigational Device Exemption (IDE), which is permission to study the device, not to sell it

Always check the FDA enforcement action databases (Warning Letters, Recalls, Safety Communications) for the company name and any of its product names. A cleared product can accumulate a significant regulatory enforcement history that reshapes the investment thesis entirely.

## FDA Status Verification Checklist for Healthcare Investors

- Search Drugs@FDA or the 510(k)/PMA/De Novo device database using the company name and product name
- Record the exact application number, approval or clearance date, and approved indication
- Pull the SSED or drug approval package to understand the evidence standard
- Cross-reference the FDA database entry against the company 10-K risk factors section on EDGAR
- Verify the FDA letter number cited in any 8-K filing matches the database record
- Search the FDA Warning Letter database and Recall database for the company and product
- Check ClinicalTrials.gov for any ongoing post-market or post-approval studies
- Confirm that any designation (Breakthrough, Fast Track) is not being described as an approval
- Verify foreign approvals are not being presented as equivalent to US FDA status
- Note any label restrictions, contraindications, or REMS requirements that affect the commercial opportunity

## How MedFuel Intel Automates This Verification Process

Manually working through every FDA database, cross-referencing EDGAR filings, and checking ClinicalTrials.gov for a single company can take several hours. For portfolio-level screening across dozens of names, it becomes impractical without tooling.

MedFuel Intel runs AI-powered due diligence reports that pull from FDA primary databases, SEC EDGAR, ClinicalTrials.gov, USPTO patent records, and PubMed in real time, then flags discrepancies between what a company claims and what the primary sources show. The Red Flag Screener is a fast way to surface misrepresented regulatory status before you spend hours on deeper diligence.

Run a free Red Flag Screener on any healthcare company at https://medfuelintel.com and get a structured regulatory status summary with primary source citations in minutes.

---

Informational only, not investment advice.

---
Source: MedFuel Intel (https://www.medfuelintel.com/geo/article/how-to-check-a-company-s-fda-approval-and-clearance-status). Grounded in primary-source-verified events; verify against SEC, FDA, and ClinicalTrials.gov before any investment decision.